Literature DB >> 6322160

Promoter-regulatory region of the major immediate early gene of human cytomegalovirus.

D R Thomsen, R M Stenberg, W F Goins, M F Stinski.   

Abstract

The DNA templates containing immediate early (IE) genes of human cytomegalovirus (CMV) were transcribed in vitro by using a HeLa cell extract. When IE region 1, 2, and 3 were used, transcription was detected qualitatively only from IE region 1. Transcription was detected with DNA representing IE region 2 when the IE region 1 promoter was not present. DNA sequence analysis of the upstream regulatory region of IE region 1 detected two distinct repeats of 19 and 18 nucleotides, both being repeated four times. A putative cruciform structure could form through the surrounding sequences with each 18-nucleotide repeat being located in the unpaired region. The potential secondary structure and the repeat sequences in the regulatory region of IE region 1 are presumably related to the high level of transcription of this IE gene.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6322160      PMCID: PMC344894          DOI: 10.1073/pnas.81.3.659

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Temporal regulation of human cytomegalovirus transcription at immediate early and early times after infection.

Authors:  M W Wathen; D R Thomsen; M F Stinski
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

2.  Synthesis of human cytomegalovirus-specified RNA and protein in interferon-treated cells at early times after infection.

Authors:  M F Stinski; D R Thomsen; J E Rodriguez
Journal:  J Gen Virol       Date:  1982-06       Impact factor: 3.891

3.  Human cytomegalovirus DNA: restriction enzyme cleavage maps and map locations for immediate-early, early, and late RNAs.

Authors:  J M Demarchi
Journal:  Virology       Date:  1981-10-15       Impact factor: 3.616

4.  Cleavage maps for human cytomegalovirus DNA strain AD169 for restriction endonucleases EcoRI, BglII, and HindIII.

Authors:  D H Spector; L Hock; J C Tamashiro
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

5.  Nucleotide sequences of the murine retrovirus Friend SFFVp long terminal repeats: identification of a structure with extensive dyad symmetry 5' to the TATA box.

Authors:  S P Clark; T W Mak
Journal:  Nucleic Acids Res       Date:  1982-05-25       Impact factor: 16.971

6.  Temporal patterns of human cytomegalovirus transcription: mapping the viral RNAs synthesized at immediate early, early, and late times after infection.

Authors:  M W Wathen; M F Stinski
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

7.  Cloning of the human cytomegalovirus genome as endonuclease XbaI fragments.

Authors:  D R Thomsen; M F Stinski
Journal:  Gene       Date:  1981-12       Impact factor: 3.688

Review 8.  Organization and expression of eucaryotic split genes coding for proteins.

Authors:  R Breathnach; P Chambon
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

9.  Cloning and complete nucleotide sequence of human 5'-alpha-globin gene.

Authors:  S A Liebhaber; M J Goossens; Y W Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

10.  Regulation of alpha genes of herpes simplex virus: expression of chimeric genes produced by fusion of thymidine kinase with alpha gene promoters.

Authors:  L E Post; S Mackem; B Roizman
Journal:  Cell       Date:  1981-05       Impact factor: 41.582

View more
  121 in total

1.  A strong negative transcriptional regulatory region between the human cytomegalovirus UL127 gene and the major immediate-early enhancer.

Authors:  C A Lundquist; J L Meier; M F Stinski
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol.

Authors:  S W Lacey; J M Sanders; K G Rothberg; R G Anderson; B A Kamen
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

3.  Negative and positive regulation by a short segment in the 5'-flanking region of the human cytomegalovirus major immediate-early gene.

Authors:  J A Nelson; C Reynolds-Kohler; B A Smith
Journal:  Mol Cell Biol       Date:  1987-11       Impact factor: 4.272

Review 4.  Chromatin-mediated regulation of cytomegalovirus gene expression.

Authors:  Matthew B Reeves
Journal:  Virus Res       Date:  2010-09-25       Impact factor: 3.303

5.  Detection of a gene cluster that is dispensable for human herpesvirus 6 replication and latency.

Authors:  Kazuhiro Kondo; Hideo Nozaki; Kazuya Shimada; Koichi Yamanishi
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  UL69 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression.

Authors:  M Winkler; S A Rice; T Stamminger
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

7.  Human cytomegalovirus ie2 negatively regulates alpha gene expression via a short target sequence near the transcription start site.

Authors:  J M Cherrington; E L Khoury; E S Mocarski
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

8.  The HIP1 binding site is required for growth regulation of the dihydrofolate reductase gene promoter.

Authors:  A L Means; J E Slansky; S L McMahon; M W Knuth; P J Farnham
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

9.  Expression of functional diphtheria toxin receptors on highly toxin-sensitive mouse cells that specifically bind radioiodinated toxin.

Authors:  J G Naglich; J M Rolf; L Eidels
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

10.  Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter.

Authors:  Ian B DeMeritt; Liesl E Milford; Andrew D Yurochko
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.